• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Serosurvey for polio antibodies.

作者信息

Biberi-Moroeanu S, Munţiu A, Stoiculescu S

机构信息

National Laboratory for the Control of Sera and Vaccines, Bucharest, Romania.

出版信息

Virologie. 1988 Oct-Dec;39(4):241-5.

PMID:2851206
Abstract

From 1982 to 1988 a serological survey was performed on 573 subjects aged 3-80 years in order to evaluate the polio immunity level of the population. The presence of neutralizing antibodies was tested using the types 1, 2 and 3 Sabin vaccine strains as well as a wild strain of poliovirus type 1 isolated in France in 1978. According to their birth date, the subjects were assigned to 4 groups. The differences between the groups consisted in the different vaccination history of the subjects as well as in their different opportunities of having been in contact with the past epidemics of poliomyelitis. The results obtained indicate a satisfactory polio immunity level in all the 4 groups: seropositives, 96.7%-98.9% for type 2, 91.8%-98.2% for type 1 (Sabin vaccine strain), 89.3%-96.6% for type 3 and 84.2%-96.4% for type 1 wild strain. The highest immunity levels were found in group D (children with recorded history of complete polio vaccination) and in group A (unvaccinated people but contemporary with the past polio epidemics). A special comment is made with respect to 14 subjects showing satisfactory antibody titres for all the three types of Sabin-vaccine strains but who have proved to be seronegative (less than 4) for the wild type 1 poliovirus strain.

摘要

相似文献

1
Serosurvey for polio antibodies.
Virologie. 1988 Oct-Dec;39(4):241-5.
2
[Status of immunity against poliomyelitis. Polio serosurvey in 1993].[脊髓灰质炎免疫状况。1993年脊髓灰质炎血清学调查]
Dtsch Med Wochenschr. 1995 Feb 24;120(8):239-44. doi: 10.1055/s-2008-1055339.
3
Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.在全球根除脊髓灰质炎战略框架下,罗马尼亚脊髓灰质炎疫苗接种覆盖率与所分离脊髓灰质炎病毒株的传播及基因进化之间的相关性。
Roum Arch Microbiol Immunol. 2009 Jul-Sep;68(3):145-50.
4
A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.希腊南部人群中针对一组重组和非重组脊灰病毒疫苗株的脊灰病毒抗体血清阳性率研究。
Clin Microbiol Infect. 2010 Nov;16(11):1672-5. doi: 10.1111/j.1469-0691.2010.03188.x.
5
Immunity of the Croatian population to poliomyelitis--a serosurvey.克罗地亚人群对脊髓灰质炎的免疫力——血清学调查
Acta Med Croatica. 1998;52(4-5):229-33.
6
Sabin and wild polioviruses from apparently healthy primary school children in northeastern Nigeria.尼日利亚东北部表面健康的小学生中的沙宾和野生脊髓灰质炎病毒。
J Med Virol. 2012 Feb;84(2):358-64. doi: 10.1002/jmv.23184.
7
The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.在全球根除脊髓灰质炎行动战略计划框架内,罗马尼亚对急性弛缓性麻痹(AFP)病例开展基于实验室的主动监测。
Roum Arch Microbiol Immunol. 2007 Jan-Jun;66(1-2):44-50.
8
Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.乌干达口服疫苗接种的半圈养黑猩猩脊髓灰质炎病毒抗体滴度评估。
J Med Primatol. 2010 Apr;39(2):123-8. doi: 10.1111/j.1600-0684.2010.00400.x. Epub 2010 Jan 25.
9
Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.1988年以色列疫情爆发前,针对脊髓灰质炎病毒野生株和疫苗株的免疫力年龄差异以及对加强免疫的反应。
Vaccine. 1993;11(1):75-81. doi: 10.1016/0264-410x(93)90342-u.
10
Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.日本口服减毒脊髓灰质炎活疫苗对1型脊髓灰质炎病毒强毒株(类萨宾株)的效力评估。
Acta Virol. 2006;50(2):139-43.